Cargando…
Comparable Renal Function at 6 Months with Tacrolimus Combined with Fixed-Dose Sirolimus or MMF: Results of a Randomized Multicenter Trial in Renal Transplantation
In a multicenter trial, renal transplant recipients were randomized to tacrolimus with fixed-dose sirolimus (Tac/SRL, N = 318) or tacrolimus with MMF (Tac/MMF, N = 316). Targeted tacrolimus trough levels were lower in the Tac/SRL group after day 14. The primary endpoint was renal function at 6 month...
Autores principales: | Van Gurp, Eveline, Bustamante, Jesus, Franco, Antonio, Rostaing, Lionel, Becker, Thomas, Rondeau, Eric, Czajkowski, Zenon, Rydzewski, Andrzej, Alarcon, Antonio, Bachleda, Petr, Samlik, Jiri, Burmeister, Dirk, Pallardo, Luis, Moal, Marie-Christine, Rutkowski, Boleslaw, Wlodarczyk, Zbigniew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952911/ https://www.ncbi.nlm.nih.gov/pubmed/20953372 http://dx.doi.org/10.1155/2010/731426 |
Ejemplares similares
-
A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation
por: Wlodarczyk, Zbigniew, et al.
Publicado: (2012) -
Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
por: Silva, Hélio Tedesco, et al.
Publicado: (2014) -
Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002) -
Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014) -
Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)